DeFronzo, R. A. 1997. “Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidaemia, and Atherosclerosis.” Netherlands Journal of Medicine. May; 50(5):191–97.

———. 1992. “Insulin Resistance, Hyperinsulinemia, and Coronary Artery Disease: A Complex Metabolic Web.” Journal of Cardiovascular Pharmacology. 20 (11 suppl.): s1–16.

———. 1981a. “Insulin and Renal Sodium Handling: Clinical Implications.” In Björntorp, Cairella, and Howard, eds., 1981, 32–41.

———. 1981b. “The Effect of Insulin on Renal Sodium Metabolism: A Review with Clinical Implications.” Diabetologia. Sept.; 21(3):165–71.

DeFronzo, R. A., J. D. Tobin, and R. Andres. 1979. “Glucose Clamp Technique: A Method for Quantifying Insulin Secretion and Resistance.” American Journal of Physiology. Sept.; 237(3):E214–23.

Del Giudice, M. E., I. G. Fantus, S. Ezzat, G. McKeown-Eyssen, D. Page, and P. J. Goodwin. 1998. “Insulin and Related Factors in Premenopausal Breast Cancer Risk.” Breast Cancer Research and Treatment. Jan.; 47(2):111–20.

Deshaies, Y., A. Dagnault, A. Boivin, and D. Richard. 1994. “Tissue-and Gender-Specific Modulation of Lipoprotein Lipase in Intact and Gonadectomised Rats Treated with D1-Fenfluramine.” International Journal of Obesity and Related Metabolic Disorders. June; 18(6):405–11.

Diamond, J. 2003. “The Double Puzzle of Diabetes.” Nature. June 5; 423(6940):599–602.

———. 1987. “The Worst Mistake in the History of the Human Race.” Discover. May; 64–66.

Dickens, F., P. J. Randle, and W. J. Whelan, eds. 1968. Carbohydrate Metabolism and Its Disorders. 2 vols. New York: Academic Press.

Dietary Guidelines Advisory Committee. 2005. “2005 Dietary Guidelines Advisory Committee Report.” U.S. Department of Health and Human Services and U.S. Department of Agriculture. Online at http://www.health.gov/DietaryGuidelines/dga2005/ report/.

Dills, W. L., Jr. 1983. “Protein Fructosylation: Fructose and the Maillard Reaction.” American Journal of Clinical Nutrition. Nov.; 58(5 suppl.):779S–787S.

Dobyns, H. F. 1989. The Pima-Maricopa. New York: Chelsea House.

———. 1978. “Who Killed the Gila.” Journal of Arizona History. 19(1):17–30.

Dole, V. P. 1956. “A Relation Between Non-Esterified Fatty Acids in Plasma and the Metabolism of Glucose.” Journal of Clinical Investigation. Feb.; 35(2):150–54.

Doll, R., and B. Armstrong. 1981. “Cancer.” In Trowell and Burkitt, eds., 1981, 93–112.

Doll, R., and R. Peto. 1981. “The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today.” Journal of the National Cancer Institute. June; 66(6):1191–308.

Donahoo, W. T., D. R. Jensen, T. Y. Shepard, and R. H. Eckel. 2000. “Seasonal Variation in Lipoprotein Lipase and Plasma Lipids in Physically Active, Normal Weight Humans.” Journal of Clinical Endocrinology & Metabolism. Sept.; 85(9):3065–68.

Donaldson, B. F. 1962. Strong Medicine. Garden City, N.Y.: Doubleday.

Donnelly, R., A. M. Emslie-Smith, I. D. Gardner, and A. D. Morris. 2000. “ABC of Arterial and Venous Disease: Vascular Complications of Diabetes.” British Journal of Medicine. April 15; 320(7241):1062–66.

Donnison, C. P. 1938. Civilization and Disease. Baltimore: William Wood.

———. 1929. “Blood Pressure in the African Native.” Lancet. Jan. 5; 213(5499):6–7.

Donohue, P. G. 1988. “Advice Softened on Table Sugar.” St. Petersburg Times. Sept. 13; 2D.

Dousset, J. C., J. B. Gutierres, and N. Dousset. 1986. “Hypercholesterolaemia After Administration of Nicotine Chewing Gum.” Lancet. Dec. 13; 328(8520):1393–94.

Drenick, E. J. 1976. “Weight Reduction by Prolonged Fasting.” In Bray, ed., 1976b, 341–61.